Thomas Jensen
Founder at ALLARITY THERAPEUTICS, INC.
Net worth: 2 $ as of 2024-05-30
Thomas Jensen active positions
Companies | Position | Start | End |
---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Director/Board Member | 2022-07-06 | - |
Chief Executive Officer | 2023-12-07 | - | |
Founder | 2021-04-05 | - | |
Chief Tech/Sci/R&D Officer | 2020-05-31 | 2023-12-07 | |
Investor Relations Contact | 2020-05-31 | 2023-12-07 | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | 2022-06-30 | - |
Chief Executive Officer | 2023-12-07 | - | |
Founder | 2003-12-31 | - | |
Chief Tech/Sci/R&D Officer | 2003-12-31 | 2023-12-07 |
Career history of Thomas Jensen
Former positions of Thomas Jensen
Companies | Position | Start | End |
---|---|---|---|
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Founder | 2005-12-31 | - |
XRGenomics Ltd. | Founder | 2012-08-31 | - |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Chief Tech/Sci/R&D Officer | - | - |
Training of Thomas Jensen
Technical University of Denmark | Undergraduate Degree |
Statistics
International
Denmark | 5 |
United Kingdom | 2 |
United States | 2 |
Operational
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Health Technology |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
XRGenomics Ltd. | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Stock Market
- Insiders
- Thomas Jensen
- Experience